Ainos, Inc. — fact timeline

Ainos, Inc. reported financial results for year ended December 31, 2025.

“On March 30, 2026, Ainos, Inc. (the “Company”) announced its financial results for the year ended December 31, 2025.”

Ainos, Inc. engaged YCM CPA Inc. as its auditor.

“On July 31, 2025, the audit committee of the board of directors of the Company (the “Audit Committee”) engaged YCM CPA Inc. (“YCM”) as the Company’s new independent registered public accounting firm”

KCCW Accountancy Corp. resigned as auditor of Ainos, Inc..

“On July 30, 2025, KCCW Accountancy Corp. (“KCCW”) resigned as independent registered public accounting firm of Ainos, Inc.”

Ainos, Inc.: Amended Restated Certificate of Formation to effect a 1-for-5 reverse stock split of common stock (effective 2025-06-30).

“Effective June 30, 2025, at 5:01 a.m., Central time (the “Effective Time”), Ainos, Inc. (the “Company”) filed a certificate of amendment (the “Certificate of Amendment”) to amend its Restated Certificate of Formation, as amended, with the Secretary of the State of Texas, to effect a reverse stock split of the Company’s common stock, par value $0.01 (the “Common Stock”) at a ratio of 1-for-5 (the “Reverse Stock Split”).”

Lawrence K. Lin changed role as Executive Vice President of Operations at Ainos, Inc..

“As of August 9, 2024, Lawrence K. Lin transitioned from his role as the Company’s Executive Vice President of Operations, effective August 9, 2024.”

Ainos, Inc. reported first quarter ended March 31, 2024 results: revenue US$20,729, net income US$3,314,810.

“Revenues were US$20,729 in the first quarter of 2024, compared to US$49,164 in the same period of 2023, reflecting the Company’s cessation of sales of its COVID-19 antigen rapid test kits during the first quarter of 2024 after a strategic pivot shift.”

Ainos, Inc. incurred convertible notes of $9,000,000 with ASE Test, Inc. at six percent compound interest maturing May 3, 2027.

“On May 3, 2024, Ainos, Inc., a Texas corporation (“Ainos”, “we” or the “Company”), entered into a Convertible Note and Warrant Purchase Agreement (the “Agreement”) with ASE Test, Inc., Taiwanese company (“ASE Test”), pursuant to which the Company issued to ASE Test a convertible note in the aggregate principal amount of US$9,000,000.”

Ainos, Inc. entered into Convertible Note and Warrant Purchase Agreement with ASE Test, Inc. valued at US$9,000,000 (effective 2024-05-03).

“On May 3, 2024, Ainos, Inc., a Texas corporation (“Ainos”, “we” or the “Company”), entered into a Convertible Note and Warrant Purchase Agreement (the “Agreement”) with ASE Test, Inc., Taiwanese company (“ASE Test”), pursuant to which the Company issued to ASE Test a convertible note in the aggregate principal amount of US$9,000,000.”

Christopher Hsin-Liang Lee was appointed as Chief Financial Officer at Ainos, Inc..

“On March 15, 2024, the Board of Directors appointed Christopher Hsin-Liang Lee as the Chief Financial Officer of Ainos, Inc. (the “Company”).”

Meng-Lin Sung resigned as Chief Financial Officer at Ainos, Inc..

“On March 13, 2024, Meng-Lin Sung, the Chief Financial Officer of Ainos, Inc. (the “Company”), resigned from her positions with the Company, effective as of such date.”